Vantage Galan 3t
Payments companies reported to CMS as associated with Vantage Galan 3t. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vantage Galan 3t, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vantage Galan 3t
These are the largest totals companies reported as associated with Vantage Galan 3t. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Daniel Chow | Orange, CA | Diagnostic Neuroimaging (Radiology) | $11,340.00 |
| Richard Barr | Youngstown, OH | Diagnostic Radiology | $7,600.00 |
| Marin Mcdonald | San Diego, CA | Neuroradiology | $7,133.99 |
| Adam Myers | Humble, TX | Diagnostic Radiology | $7,120.00 |
| Iman Khodarahmi | New York, NY | Diagnostic Radiology | $5,840.00 |
| Jordan Gross | Los Angeles, CA | Diagnostic Radiology | $5,840.00 |
| George Matcuk | West Hollywood, CA | Diagnostic Radiology | $5,840.00 |
| Mark Winkler | Las Vegas, NV | Diagnostic Radiology | $5,208.61 |
| Kevin Berger | Annapolis, MD | Diagnostic Radiology | $4,671.02 |
| Vinay Prabhu | New York, NY | Diagnostic Radiology | $4,640.00 |
Prescribed Vantage Galan 3t?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.